Omega Healthcare Investors, Inc. announced its Q3 2024 results, featuring a net income of $115 million, or $0.42 per common share, and adjusted Funds From Operations (FFO) of $203 million, or $0.74 per common share. The company completed $440 million in new investments during the quarter and increased its full-year AFFO guidance to $2.84 to $2.86 per share.
Net income for the quarter was $115 million, or $0.42 per common share.
Nareit Funds From Operations (FFO) for the quarter was $196 million, or $0.71 per common share.
Adjusted Funds From Operations (AFFO) for the quarter was $203 million, or $0.74 per common share.
Completed $440 million in new investments in Q3, including real estate acquisitions and loans.
The Company increased its expected 2024 Adjusted FFO range to be between $2.84 to $2.86 per diluted share from the previous range of $2.78 to $2.84 per diluted share.
Visualization of income flow from segment revenue to net income